N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial.
about
Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonatesN-acetylcysteine -- passe-partout or much ado about nothing?Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung DiseaseAn update on pharmacologic approaches to bronchopulmonary dysplasiaNeuroprotective therapies after perinatal hypoxic-ischemic brain injury.Effects of post-resuscitation treatment with N-acetylcysteine on cardiac recovery in hypoxic newborn piglets.Synergistic neuroprotective therapies with hypothermia.A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants.Antenatal pharmacokinetics and placental transfer of N-acetylcysteine in chorioamnionitis for fetal neuroprotectionThe role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung diseaseDevelopmental regulation of antioxidant enzymes and their impact on neonatal lung diseaseOxygen toxicity and reactive oxygen species: the devil is in the details.New antioxidant drugs for neonatal brain injury.Perinatal oxygen in the developing lung.The biological basis of injury and neuroprotection in the fetal and neonatal brain.Association between oxidative DNA damage and the expression of 8-oxoguanine DNA glycosylase 1 in lung epithelial cells of neonatal rats exposed to hyperoxiaProtective effects of N-acetyl-L-cysteine in human oligodendrocyte progenitor cells and restoration of motor function in neonatal rats with hypoxic-ischemic encephalopathyCurrent pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia.Effect of High-Dose Cysteine Supplementation on Erythrocyte Glutathione: A Double-Blinded, Randomized Placebo-Controlled Pilot Study in Critically Ill NeonatesLung injury and bronchopulmonary dysplasia in newborn infants.Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal miceFetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis.Progress in discovery and evaluation of treatments to prevent bronchopulmonary dysplasia.Amifostine reduces lung vascular permeability via suppression of inflammatory signallingInhaled nitric oxide for the prevention of bronchopulmonary dysplasia.Neuroprotective interventions: is it too late?Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status.Oxygen and oxidative stress in bronchopulmonary dysplasia.New pharmacologic and therapeutic approaches for hypoxic-ischemic encephalopathy in the newborn.Role of amino acid supplementation in the prevention of necrotizing enterocolitis in preterm neonates - a review of current evidences.Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia.Thiol metabolism in preterm infants during the first week of life.Early inhaled nitric oxide improves oxidative balance in very preterm infants.Bone marrow mesenchymal stem cells attenuate lung inflammation of hyperoxic newborn rats.
P2860
Q24243990-2673AF64-BD65-4022-B1F6-50AA97A0036EQ24678741-E86BBE90-9451-4A0D-9687-C600927823B7Q26798069-47A9AAD8-1FDD-4107-8406-A79DC1E342DEQ26825139-352EE652-71F6-4AA6-BD2A-EA98D8BB7CD7Q33772042-76F481F3-D94A-48ED-A4E7-F5BF82A858F2Q33784750-F9A5A214-66FF-4AA7-9EBA-B28546AB6CA7Q33943360-25583C43-866D-4B28-9765-9FD8FE6023D2Q34123512-6E818859-6ED4-4F52-ADC1-76ABC9DC40A8Q34254616-FE6AEF64-92B0-47AB-BC87-272F6DF8228CQ34370825-AB3CB1AB-B829-49BC-8CA0-33A28AEC2759Q34371022-F5EF4394-2D7E-4FE2-BF9D-2470ACC2A804Q34977549-6B6FA225-A174-4836-9063-57827ED12BE5Q35037632-81E1D939-689E-4C12-B967-18732B26827CQ35037758-1A60E7CF-D364-43EF-A559-DD563626A205Q35201430-D2ED9C99-9195-4F24-A5D5-669C76D4B7F4Q35387786-498B1896-6EDF-4FC0-B71C-0B7D65EDE977Q35415534-DD44E80E-961F-4BEC-AFB5-3BC2AD0967CBQ35675944-3506B4D6-3864-4518-AA9C-6D47B7EDC55DQ36070592-E0F135D5-90B6-4902-B2BC-AC4936F07CF0Q36108257-31BAB0DC-3572-4060-9B8F-C86790F2797FQ36178212-1ABAC1DF-3990-45A1-A8B4-72A03B2DFE5FQ36421226-F3DDFFDE-A7B1-4419-AD01-DD49CCBD9F99Q36504539-B21937C7-E9C2-4041-8BF4-580746AB371AQ36866297-E7ECAF82-9529-4E0B-AAC3-2B3EA07DB881Q36895849-1EC38030-5959-4714-B18A-F68DCD0841CDQ36907373-DB5EA92B-E8F4-4F56-B244-5B43AE2B82C4Q37405102-53ED3A04-3514-4422-B7C6-7E7076A4116DQ37419183-44F49A6B-BD00-4792-81AE-AFF5E33F9265Q37784210-F012352D-0594-4B89-8252-2229FEE90F0EQ37981711-EEBADFEA-A700-4FC4-B9D1-7AC316E6828AQ39373800-C9063CD9-CBF6-44FE-BB8C-8DA97322CC26Q44885197-DAC9AD73-D72B-4306-A19E-1C51045A213EQ45129493-9F2169D9-8DE7-4E7A-9E0A-FDAC9EF29084Q45299611-55BD6923-5BC6-4596-B9DB-EEB80D6164A2Q50494520-57269059-A65A-4D5F-8C81-EE473CE6383B
P2860
N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
N-acetylcysteine does not prev ...... a randomized controlled trial.
@en
N-acetylcysteine does not prev ...... a randomized controlled trial.
@nl
type
label
N-acetylcysteine does not prev ...... a randomized controlled trial.
@en
N-acetylcysteine does not prev ...... a randomized controlled trial.
@nl
prefLabel
N-acetylcysteine does not prev ...... a randomized controlled trial.
@en
N-acetylcysteine does not prev ...... a randomized controlled trial.
@nl
P2093
P1476
N-acetylcysteine does not prev ...... a randomized controlled trial.
@en
P2093
Baldvin Jonsson
Bo Selander
Finn Jonsbo
Gitte Esberg
Kari O Raivio
Kristin Lossius
Kristina Virkola
Lennart Stigson
Risto Lapatto
Sveinn Kjartansson
P304
P356
10.1067/S0022-3476(03)00419-0
P407
P577
2003-12-01T00:00:00Z